Market cap
₹1,430 Cr
Recently Viewed
Clear AllBSE: 524520
₹87.70
₹0.13
(0.15%)
As on 30-Apr-2026IST
Market cap
₹1,430 Cr
Revenue (TTM)
₹284 Cr
P/E Ratio
39
P/B Ratio
7.3
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹37 Cr
ROE
13.9 %
ROCE
18 %
Industry P/E
49.42
EV/EBITDA
18.1
Debt to Equity
0.5
Book Value
₹12
EPS
₹2.2
Face value
1
Shares outstanding
163,085,000
CFO
₹237.77 Cr
EBITDA
₹278.42 Cr
Net Profit
₹150.57 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
KMC Spec Hosp
| 15.8 | 8.9 | 15.1 | 25.2 | 12.7 | 21.2 | 25.0 |
|
BSE Healthcare
| 2.7 | 6.8 | 7.9 | 5.7 | 24.7 | 13.8 | 11.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
KMC Spec Hosp
| -1.4 | -10.4 | 30.5 | -11.8 | 238.9 | 52.0 | 8.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
KMC Spec Hosp
|
87.7 | 1,430.3 | 284.5 | 36.6 | 19.9 | 21.1 | 39 | 7.3 |
| 244.1 | 3,871.4 | 1,041.9 | 96.4 | 12.0 | 11.5 | 40.1 | 3.3 | |
| 701.1 | 36,341.0 | 4,643.2 | 464.1 | 13.7 | 8.9 | 93.6 | 7.9 | |
| 445.1 | 14,084.0 | 1,976.2 | 160.7 | 14.1 | 6.7 | 111.7 | 7.1 | |
| 572.6 | 8,548.3 | 2,478.2 | 24.7 | 8.4 | 4.2 | 451.1 | 6.4 | |
| 402.1 | 3,692.6 | 1,451.5 | 182.9 | 15.5 | 29.2 | 20.2 | 5.3 | |
| 1,225.9 | 8,051.8 | 1,433.4 | 188.7 | 17.4 | 13.8 | 42.7 | 5.4 | |
| 5,657.6 | 6,199.3 | 1,529.9 | 235.8 | 21.2 | 20.7 | 26.3 | 4.9 | |
| 1,252.3 | 12,731.5 | 1,613.3 | 259.9 | 23.0 | 17.3 | 49.4 | 8.0 | |
| 820.0 | 7,894.3 | 1,089.4 | 165.1 | 17.4 | 10.2 | 47.2 | 4.6 |
No Review & Analysis are available.
Hospital activities
Incorporated
1982
Chairman
S Chandrakumar
Managing Director
S Manivannan
Headquarters
Trichy, Tamil Nadu
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of KMC Speciality Hospitals (India) Ltd is ₹87.70 (BSE) as of 30-Apr-2026 IST. KMC Speciality Hospitals (India) Ltd has given a return of 12.72% in the last 3 years.
The P/E ratio of KMC Speciality Hospitals (India) Ltd is 39.05 times as on 30-Apr-2026, a 21 discount to its peers’ median range of 49.42 times.
The P/B ratio of KMC Speciality Hospitals (India) Ltd is 7.30 times as on 30-Apr-2026, a 1 premium to its peers’ median range of 7.24 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
46.73
|
6.09
|
|
2024
|
43.57
|
9.22
|
|
2023
|
35.16
|
8.27
|
|
2022
|
38.25
|
10.46
|
|
2021
|
27.82
|
5.61
|
The 52-week high and low of KMC Speciality Hospitals (India) Ltd are Rs 92.90 and Rs 61.00 as of 02-May-2026.
KMC Speciality Hospitals (India) Ltd has a market capitalisation of ₹ 1,430 Cr as on 30-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in KMC Speciality Hospitals (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.